Hyro, a conversational‑AI platform built for healthcare enterprises, has announced a $45 million strategic growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and strategic investors including Bon Secours Mercy Health and ServiceNow Ventures. The financing comes just ten months after Hyro’s previous raise and brings its total funding to approximately $95 million.
Co‑founded by Israel Krush (Chief Executive Officer) and Rom Cohen (Chief Information Officer), the company operates from New York and serves more than 45 major health systems, with over 30 million patients already engaging via its AI‑powered chat and voice agents. Hyro’s platform supports administrative, operational and clinical workflows across voice, SMS, mobile apps and web channels, with its newly launched Proactive Px™ module enabling inbound and outbound communications at scale.
“After another 10 months of strong execution, landing new enterprise customers and expanding relationships with existing ones, we decided to bring on additional capital to further our mission of improving patient access to care and driving operational excellence for health systems,” said Israel Krush. “There are plenty of impressive demos in the market, but what healthcare organisations need are AI agents that are patient‑ready and enterprise‑ready today, designed around proven real‑world workflows and best practices, deeply interoperable with EMR systems like Epic, and reinforced with robust safeguards.”
Amir Dan Rubin, CEO & Founding Managing Partner of Healthier Capital, added: “Hyro’s team, technology, traction and client‑earned trust demonstrates an ability to deliver significant positive impacts at scale in healthcare.”
Hyro’s technical architecture merges large language models (LLMs) with proprietary small‑language models (SLMs) and knowledge graphs tailored for healthcare. The company claims its agents can resolve up to 85 % of routine patient inquiries—such as registration, scheduling or prescription questions—while integrating with core systems like electronic medical records and customer‑relationship management tools.
Editorial Insight
This funding announcement doubles down on the conviction that healthcare’s next productivity frontier lies far beyond basic symptom‑checkers or off‑the‑shelf chatbots. With burnout and staffing shortages rife, health‑system leaders are facing patient‑access crunches and rising expectations for digital‑first interactions. Hyro is aiming to become the connective tissue between patients, operational workflows and enterprise systems—wrapping AI around healthcare’s noisy edges rather than simply offering a new app.
Still, the road ahead demands more than capital—execution will define the difference. Managing regulatory‑compliance, ensuring seamless hand‑offs from AI to human agents, and delivering measurable retention and access metrics will separate the pilots from the platform plays. If Hyro delivers real‑world results at scale in year two, it may become one of the few healthcare‑AI providers whose name enters procurement conversations rather than being dismissed as yet another experimentation tool.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
